Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula

While the patency of vascular access is essential for hemodialysis patients, optimal pharmaceutical treatment to maintain arteriovenous fistula (AVF) patency remains lacking. As cardiovascular diseases are highly prevalent in patients with end-stage renal disease, various cardiovascular medications...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Te-I., Chen, Cheng-Hsien, Hsieh, Hui-Ling, Chen, Chun-You, Hsu, Shih-Chang, Cheng, Ho-Shun, Huang, Wen-Cheng, Sue, Yuh-Mou, Hsu, Yung-Ho, Lin, Feng-Yen, Shih, Chun-Ming, Lin, Shing-Jong, Huang, Po-Hsun, Liu, Chung-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376157/
https://www.ncbi.nlm.nih.gov/pubmed/32699337
http://dx.doi.org/10.1038/s41598-020-69019-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376157/
https://www.ncbi.nlm.nih.gov/pubmed/32699337
http://dx.doi.org/10.1038/s41598-020-69019-6

Ejemplares similares